Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Nitric oxide-releasing nanoparticles: synthesis, characterization, and cytotoxicity to tumorigenic cells

Full text
Author(s):
Pelegrino, Milena T. [1, 2] ; Silva, Letecia C. [2] ; Watashi, Carolina M. [2] ; Haddad, Paula S. [1] ; Rodrigues, Tiago [2] ; Seabra, Amedea B. [2]
Total Authors: 6
Affiliation:
[1] Univ Fed Sao Paulo, Exact & Earth Sci Dept, Rua Sao Nicolau 210, BR-09913030 Diadema, SP - Brazil
[2] Univ Fed ABC, UFABC, Ctr Nat & Human Sci, Ave Estados 5001, CEP Bairro Bangu Bloco A, Torre 3, BR-09210580 Santo Andre, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: JOURNAL OF NANOPARTICLE RESEARCH; v. 19, n. 2 FEB 8 2017.
Web of Science Citations: 12
Abstract

Nitric oxide (NO) is involved in several biological processes, including toxicity against tumor cells. The aim of this study was to synthesize, characterize, and evaluate the cytotoxicity of NO-releasing chitosan nanoparticles. A thiol-containing molecule, mercaptosuccinic acid (MSA), was encapsulated (encapsulation efficiency of 99%) in chitosan/sodium tripolyphosphate nanoparticles (CS NPs). The obtained nanoparticles showed an average hydrodynamic size of 108.40 +/- 0.96 nm and polydispersity index of 0.26 +/- 0.01. MSA-CS NPs were nitrosated leading to S-nitroso-MSA-CS NPs, which act as NO donor. The cytotoxicity of CS NPs, MSA-CS NPs, and S-nitrosoMSA- CS NPs were evaluated in several tumor cells, including human hepatocellular carcinoma (HepG2), mouse melanoma (B16F10), and human chronic myeloid leukemia (K562) cell lines and Lucena-1, a vincristine-resistant K562 cell line. Both CS NPs and MSA-CS NPs did not cause toxic effects in these cells, whereas S-nitroso-MSA-CS NPs caused potent cytotoxic effects in all the tested tumor cell lines. The halfmaximal inhibitory concentration values of S-nitroso-MSA-CS NPs were 19.7, 10.5, 22.8, and 27.8 mu g.mL(-1) for HepG2, B16F10, K562, and Lucena-1 cells, respectively. In contrast, S-nitroso-MSA-CS NPs exhibited lower cytotoxic to non-tumorigenic melanocytes (Melan-A) when compared with melanoma B16F10. Therefore, the results highlight the potential use of NO-releasing CS NPs in antitumor chemotherapy. (AU)

FAPESP's process: 15/00393-8 - Nitric oxide releasing polymeric nanoparticles for topical applications
Grantee:Milena Trevisan Pelegrino
Support type: Scholarships in Brazil - Master
FAPESP's process: 16/10347-6 - S-nitrosothiol containing nanoparticles: synthesis, characterization, cytotoxicity and applications
Grantee:Amedea Barozzi Seabra
Support type: Regular Research Grants
FAPESP's process: 14/13913-7 - Preparation, characterization and biological evaluations of mono and bimetallic nanoparticles systems
Grantee:Paula Silvia Haddad Ferreira
Support type: Regular Research Grants